The prevalence of idiopathic hypercalciuria (IH) in healthy pediatric population ranges from 3.0% to 7.0%. There is insufficient data about IH in children with mono-symptomatic enuresis. The aim of this study was to examine calcium excretion in urine (UCa) in patients with primary mono-symptomatic nocturnal enuresis (PMNE). Methods: In patients with PMNE, aged 5 to 17 years, IH was determined in 24-h urine and from second morning spot urine. The completeness of the 24-h urine collections was estimated via measuring 24h-urine creatinine excretion (UCr) of 0.1-0.2 mmol/kg/24h. Results: Sixty patients with PMNE, 32 males and 28 girls, median age of 9 years were enrolled in the study. Only 41.7% patients successfully completed 24 h urine collection. IH, defined as 24-h UCa > 0.1 mmol/kg body weight, was diagnosed in 12% of the patients, while when defined as UCa/UCr > 0.8 mmol/mmol in children 5-7 years and > 0.6 mmol/mmol in those > 7 years, IH was 8.3% and 6.7% from 24h-urine and spot urine, respectively. Conclusion: Children and adolescents with PMNE are in risk of hypercalciuria. Therefore, it is useful to examine 24 hours of urine calcium excretion in these patients.
INTRODUCTION
Nocturnal enuresis or bedwetting is an involuntary voiding during sleep in children aged more than 5 years. It is a primary when children have never achieved six months of continuously dry nights, or it is a secondary which occur after at least 6 months of nighttime voiding control. Nocturnal enuresis is common in children. However, its prevalence decreases with increasing age of the child. The Avon Longitudinal Study of Parents and Children found that the prevalence of bedwetting < 2 nights per week is 30% at age of 4.5 years and 8% at 9.5 years, and the prevalence of bedwetting ³ 2 nights per week is 8% at 4.5 years and 1.5% at 9.5 years (1) . In another studies, about 10% of all 7-yr-old children, 5% of all 10-yr-olds and 0.5-1% of adults were affected more than three times bedwetting per week (2, 3) .
Nocturnal enuresis is very distressing condition that can have a deep impact on the child/young person's behavior and on their emotional and social life (4, 5) . It also disturbs a quality of life among the parents or guardians (6) .
According to the Standardization Committee of the International Children's Continence Society (ICCS) the term mono-symptomatic nocturnal enuresis (MNE) signifies that children have enuresis only when asleep while the term non-mono-symptomatic nocturnal enuresis (NMNE) describes the symptoms of children who have urinary incontinence at night and also have day time voiding symptoms (7) . An estimated 80 percent of children with nocturnal enuresis have MNE form.
The pathophysiology of primary MNE (PMNE) is complex and so far it has not yet been fully clarified. An altered circadian profile of antidiuretic hormone, arousal failure and delayed urinary bladder maturation are the best studied pathophysiological factors (8 Original article Kamperis et al. documented that polyuric patients with MNE refractory to desmopressin treatment excrete larger amounts of sodium and urea at night compared with healthy controls and nonpolyurics MNE patients despite a normal the circadian rhythm of sodium-regulating hormones such as atrial natriuretic peptide, angiotensin II, aldosterone, and renin levels but may be secondary to augmented urinary prostaglandin E2 (PGE2) excretion (9) . Some authors found idiopathic hypercalciuria (IH) to be more common in children with PMNE than in children without nocturnal enuresis and for this reason they assume that IH could be one of the contributing pathophysiologic factor to PMNE (10, 11, 12) . Considering 24 h-variations in urine calcium excretion, the diagnosis of hypercalciuria is most accurately determined from the urine collected for 24 h. This is usually difficult to achieve in children who have nocturnal enuresis. In situations where 24h-urine collection is not possible, random urine measurements are implemented, using spot urine ratio of the calcium and creatinine and comparing it with its age-related reference values (10, 13) .
The aim of this study was to examine calcium excretion in urine collected for 24 hours and from the second morning spot urine in children and adolescents with PMNE, and to estimate the frequency of hypercalciuria.
MATERIAL AND METHODS
All consecutive children and adolescents referred from September 2017 to May 2018 to Pediatric Hospital in Novi Pazar (a city located in the Ra{ka District of southwestern Serbia), due to nocturnal enuresis, were considered to be included in this study. Inclusion criteria for the study were: 1) Patients with PMNE, age 5 to 17 years, 2) completed 24-h urine collection, 3) normal renal function and 4) normal serum electrolytes including calcium level. Exclusion criteria were as follows: (1) urinary tract infections in anamnesis, (2) signs of any acute infection before examination, (3) secondary nocturnal enuresis, and NMNE, (4) no idiopathic hypercalciuria, (5) metabolic diseases, (6) renal stone diseases, (7) impaired kidney function, (8) kidney and urinary tract anomalies, (9) and any pharmacological treatment or diet supplementation in past 6 months (calcium, Vitamin D).
The clinical work up were done in all patients consisting of collecting data to determine age, gender, present and past medical history, daytime and nighttime voiding patterns, bowel emptying habits, family history for nocturnal enuresis and renal stone diseases, and complete physical examination. Laboratory analyzes that included serum urea, creatinine, complete blood count, fasting blood sugar and electrolytes, urinary electrolytes and creatinine levels were tested in all patients. Kidney and bladder ultrasound were also done. Twenty-four hour urine samples were collected for each patient to measure calcium (UCa) and creatinine (UCr). To prevent urine loss the enuretic children were waking up at least two times during night. The completeness of the 24-h urine collections was estimated via measuring 24h-urine creatinine of 0.1-0.2 mmol/kg/24h (14) . Urine calcium from 24 h urine was expressed in mmol/kg body weight (BW) and in mmol/l per kg BW. UCa and UCr were determined also in spot urine from second urine sample. Urinary tract infections were excluded on the basis of urinary testing.
PMNE was defined as involuntary nocturnal bedwetting ³ twice a week for ³ 3 consecutive months in children of ³ 5 years of age who have never gained control over night time voiding, but without any low urinary tract problems during the daytime. Idiopathic hypercalciuria (IH) was diagnosed if urine calcium excretion was ³ 0.1 mmol kg/day in the 24 h urine or urine calcium to creatinine ratio of more than 0.6 mmol/mmol in urine samples in children aged > 7 years and > 0.8 mmol/mmol in those aged 5-7 years (10). Patients were divided into two groups, the first (I) consisted of normocalciuric children with PMNE and the second one (II) included hypercalciuric children with PMNE. The demographic data, urine calcium level as well as family history for nocturnal enuresis and renal stone diseases were compared between groups. Data analysis was performed using SPSS version 21 software. Normal distribution of data was tested with the Shapiro-Wilk W test. Quantitative variables were provided as median and interquartile (IQR) range, while qualitative ones were presented as a percentage. The variables were compared using Student's "t" test, Mann-Whitney U-test and chi-square test, where it was appropriate. A p value < 0.05 was considered statistically significant.
Written informed consent was obtained from all the enrolled subjects, subsequent to receive full information about the study. The study was approved by the Ethics Committee of General Hospital Novi Pazar in accordance with the Declaration of Helsinki.
RESULTS
Sixty patients with PMNE, 32 males and 28 girls, median age of 9 (IQR 7.0-12.7) years were enrolled in the study. Only 25 (41.66%) patients successfully completed 24 h urine collection with median 24-h UCr of 0.16 (IQR 0.12-0.18). Hypercalciuria, defined for all ages as 24-h Ucr > 0.1 mmol/kg body weight, was diagnosed in three patients (12% Positive family for nephrolithiasis (%) 1 (4%) 0 (0) 1 (4.50%) ns PMNE = Primary monosymptomatice nocturnal enuresis; IQR = interquartile range (25-75 percentile), * For group I IQR was presented only as 25 and 50 percentile due to small number of the patients; UCa = Calcium in urine; UCr = creatinine in urine; UCa/UCr = ratio of urinary calcium and creatinine; ns = not significant tics of the patients with (group I) and without (group II) hypercalciuria are presented in Table 1 . There were no statistically significant differences between these groups neither in age, gender, body height (BH), body weight (BW), body mass index (BMI), nor in family history for NE and renal stone diseases. As expected the patients with IH had significantly higher UCa and UCa/UCr in 24h-urine. In addition, the median 24 h urine calcium (mmol/l)/body weight (kg) ratio was also higher in the group I than in the group II. Urine calcium/creatinine ratio in spot urine was higher in group I than in group II, but the difference did not reach statistical significance. Only one patient, who belongs to group I had increased ratio of urinary Ca and creatinine from 24h-urine as well as from spot urine.
Hypercalciuria may be diagnosed also according to UCa/UCr ratio when it is > 0.8 mmol/mmol in children aged 5-7 years and > 0.6 mmol/mmol in those aged > 7 years. Using these criteria for 24h-urine and for spot urine hypercalciuria was found in 8.33% and 6.67% of all patients with PMNE, respectively (See Table 2 ). In addition, the median 24 h urine calcium expressed in mmol/l and body weight ratio was higher in the group with hypercalciuria (group 1) than in the group with normal calciuria (group 2).
A positive family history of nocturnal enuresis was found in 40 to 60.7% of patients, depending on how they were classified. In contrast, a positive history of nephrolithiasis was found in a significantly smaller number (0% to 12%) of patients.
DISCUSSION
Idiopathic hypercalciuria (IH) is defined by hypercalciuria, normocalcemia, and the absence of diseases known to cause increased urine calcium excretion (15) . Pathogenesis of IH is very complex and many potential factors can be involved, such as polymorphisms of the gene coding for proteins regulating tubular phosphate and calcium reabsorption and those responsible for proteins preventing calcium salt precipitation or gene coding for a water channel in the proximal tubule (16) . Furthermore, in families with an autosomal dominant mode of IH, inheritance connection between IH and loci on chromosome 1q23.3-q24, which contains the human soluble adenylyl cyclase gene, chromosome 12q12-q14, which contains the VDR gene and chromosome 9q33.2-q34.2, were established (17) . Environmental factors may also significantly affect renal stone formation. Nutrient intake may change urine composition, but may also influence gene expression by epigenetic mechanisms.
The idea that IH may be an important pathogenic factor of nocturnal enuresis was first proposed by Pace et al. (18) who noted that a proportion of enuretic children had absorptive hypercalciuria. Since that time some strategies were made to measure urinary calcium excretion in the evaluation of nocturnal enuresis (19, 20) . It has come so far that the therapeutic response of desmopressin link to the reduction of hypercalciuria as has been demonstrated in some Italian studies (21, 22) . However, there are opposing opinions about the possible relationship between hypercalciuria and enuresis. Neveus et al. in their study concluded that the urinary calcium excretion does not differ between enuretic and dry children (23). Kamperis et al. in another study observed no significant difference among calcium excretion of children with or without nocturnal enuresis (24) . Different data on the frequency of IH in children with nocturnal enuresis can be explained by heterogeneity in its etiopatogenesis as well as by differences in the methodology of testing or measurement of calcium in the urine.
It is well known that hypercalciuria can be presented with different symptoms associated with urinary symptoms (25, 26) . Recently, Esteghamati et al found the prevalence of idiopathic hypercalciuria is 48.3% in children with urinary tract infection, 54.9% and 53.6% in children with microscopic and macroscopic hematuria respectively, 52.1% and 51.8% in children with dysuria and in children with frequency respectively, 49.1% in children with kidney stone, and 28.6% and 37.5% in children with nocturnal and daily urinary incontinency respectively (27). There is insufficient data about IH in monosymptomatic enuresis.
In the present study we found hypercalciuria in 12% of the patients with PMNE when calcium in urine was determined in properly collected 24 h urine, but only in 8% and in 6.7% of the patients when it was estimated on the basis of calcium and creatinine ratio in 24 h and spot urine, respectively. The prevalence of IH in the healthy pediatric population is considerable, and the authors have reported rates between 3.0% and 7.0% among children (26, 28) . Our data confirmed the greater sensitivity of calciuria from 24 h urine compared to spot urine calciuria. Although the determination of calciuria is much more reliable at 24 h urine, proper urine collection for 24 h is very difficult to perform in children with bedwetting. Only 41.7% of our patients managed to properly collect the urine for 24 h. Like other authors (29) we found a strong family history of bedwetting in children and adolescents with PMNE.
Our study has some limitations. One of the limitations in this study was the difficulty of 24-hour urine collection, and, therefore a relatively small number of patients with PMNE who succeed urine collection. Another limitation of the study is the lack of a control group. We suggest that IH in children with PMNE should be examined from 24 h urine in a larger group of children.
